Long-term safety and tolerability of bimekizumab in patients with axial spondyloarthritis and psoriatic arthritis: Results from pooled phase 2b/3 studies

被引：0

作者：

Mease, P. J. ^{[1
,2
]}

Poddubnyy, D. ^{[3
]}

Orbai, A. M. ^{[4
]}

Warren, R. B. ^{[5
,6
]}

Fleurinck, C. ^{[7
]}

Bajracharya, R. ^{[8
]}

Ink, B. ^{[8
]}

Massow, U. ^{[9
]}

Shende, V ^{[8
]}

Shepherd-Smith, J. ^{[8
]}

Peterson, L. ^{[10
]}

White, K. ^{[8
]}

Landewe, R. ^{[11
]}

Gensler, L. S. ^{[12
]}

机构：

[1] Univ Washington, Swedish Med Ctr, Seattle, WA 98195 USA

[2] Univ Washington, Prov St Joseph Hlth, Seattle, WA 98195 USA

[3] Charite Univ Med Berlin, Dept Gastroenterol Infect Dis & Rheumatol, Berlin, Germany

[4] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA

[5] Northern Care Alliance NHS Fdn Trust, Dermatol Ctr, Manchester, Lancs, England

[6] Univ Manchester, NHS Fdn Trust, NIHR Manchester Biomed Res Ctr, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England

[7] UCB Pharma, Brussels, Belgium

[8] UCB Pharma, Slough, Berks, England

[9] UCB Pharma, Monheim, Germany

[10] UCB Pharma, Morrisville, NY USA

[11] Amsterdam & Zuyderland MC, Amsterdam Rheumatol & Clin Immunol Ctr, Heerlen, Netherlands

[12] Univ Calif San Francisco, San Francisco, CA 94143 USA

来源：

SWISS MEDICAL WEEKLY | 2024年 / 154卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

IP 7

引用

页码：35S / 35S

页数：1

共 50 条

[1] Long-term Safety and Tolerability of Bimekizumab in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: Results from Pooled Phase 2b/3 Studies
Mease, Philip J.
Poddubnyy, Denis
Orbai, Ana-Maria
Warren, Richard B.
Fleurinck, Carmen
Bajracharya, Rajan
Ink, Barbara
Massow, Ute
Shende, Vishvesh
Shepherd-Smith, Julie
Peterson, Luke
White, Katy
Landewe, Robert B. M.
Gensler, Lianne
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 1000 - 1003
[2] Updated Long-Term Safety and Tolerability of Bimekizumab in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: Pooled Results from Phase 2b/3 Studies
Mease, Philip
Poddubnyy, Denis
Bajracharya, Rajan
Ink, Barbara
Marten, Alexander
Massow, Ute
Shende, Vishvesh
Manente, Myriam
Peterson, Luke
White, Katy
Nash, Peter
Gensler, Lianne S.
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4786 - 4789
[3] Low Uveitis Rates in Patients with Axial Spondyloarthritis or Psoriatic Arthritis Treated with Bimekizumab: Long-Term Results from Phase 2b/3 Trials
van der Horst-Bruinsma, Irene E.
Brown, Matthew A.
van Gaalen, Floris
Haroon, Nigil
Gensler, Lianne S.
Marten, Alexander
Manente, Myriam
Stojan, George
Vaux, Thomas
White, Katy
Deodhar, Atul
Rudwaleit, Martin
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4741 - 4743
[4] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
Baraliakos, Xenofon
Deodhar, Atul
van der Heijde, Desiree
van den Bosch, Filip
Magrey, Marina
Maksymowych, Walter P.
Tomita, Tetsuya
Xu, Huji
Massow, Ute
Vaux, Tom
Prajapati, Chetan
Manente, Myriam
Marten, Alexander
Gensler, Lianne S.
RHEUMATOLOGY, 2025,
[5] LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS
Rudwaleit, M.
Brown, M.
Van Gaalen, F. A.
Haroon, N.
Gensler, L. S.
Fleurinck, C.
Marten, A.
Massow, U.
De Peyrecave, N.
Vaux, T.
White, K.
Deodhar, A.
Van der Horst-Bruinsma, I.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 614 - 615
[6] Low uveitis rates in patients with axial spondyloarthritis treated with bimekizumab: pooled results from phase 2b/3 trials
Brown, Matthew A.
Rudwaleit, Martin
van Gaalen, Floris A.
Haroon, Nigil
Gensler, Lianne S.
Fleurinck, Carmen
Marten, Alexander
Massow, Ute
de Peyrecave, Natasha
Vaux, Thomas
White, Katy
Deodhar, Atul
van der Horst-Bruinsma, Irene
ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (12) : 1722 - 1730
[7] Low Uveitis Rates in Patients with Axial Spondyloarthritis Treated with Bimekizumab: Pooled Results from Phase 2b/3 Trials
Rudwaleit, Martin
Brown, Matthew A.
Van Gaalen, Floris
Haroon, Nigil
Gensler, Lianne
Fleurinck, Carmen
Marten, Alexander
Massow, Ute
De Peyrecave, Natasha
Vaux, Thomas
White, Katy
Deodhar, Atul
van der Horst-Bruinsma, Irene
ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5060 - 5062
[8] LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS
Rudwaleit, Martin
Brown, Matthew A.
van Gaalen, Floris Alexander
Haroon, Nigil
Gensler, Lianne S.
Fleurinck, Carmen
Marten, Alexander
Massow, Ute
de Peyrecave, Natasha
Vaux, Thomas
White, Katy
Deodhar, Atul
McGonagle, Dennis
van der Horst-Bruinsma, Irene
RHEUMATOLOGY, 2024, 63
[9] LOW UVEITIS RATES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB: POOLED RESULTS FROM PHASE 2B/3 TRIALS
Rudwaleit, Martin
Brown, Matthew A.
van Gaalen, Floris Alexander
Haroon, Nigil
Gensler, Lianne S.
Fleurinck, Carmen
Marten, Alexander
Massow, Ute
de Peyrecave, Natasha
Vaux, Thomas
White, Katy
Deodhar, Atul
McGonagle, Dennis
van der Horst-Bruinsma, Irene
RHEUMATOLOGY, 2024, 63
[10] Low Uveitis Rates in Patients With Axial Spondyloarthritis Treated With Bimekizumab: Pooled Results From Phase 2B/3 Trials
Bessette, Louis
Rudwaleit, Martin
Brown, Matthew
van Gaalen, Floris
Haroon, Nigil
Gensler, Lianne
Fleurinck, Carmen
Marten, Alexander
Massow, Ute
de Peyrecave, Natasha
Vaux, Thomas
White, Katy
Deodhar, Atul
van der Horst-Bruinsma, Irene
JOURNAL OF RHEUMATOLOGY, 2024, 51 : 67 - 68

← 1 2 3 4 5 →